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Summary We have assessed the role of tumour necrosis factor-a (TNF) during 
cutaneous leishmaniasis and demonstrated that significant levels of TNF were 
released by spleen cells from infected mice after in cirro restimulation with 
Leishmania major promastigotes. Spleen cells from both genetically resistant and 
genetically susceptible mice were equally capable of producing TNF. After 
challenge with bacterial endotoxin, TNF activity could also be demonstrated in 
the serum of L. mujor-infected mice and the titres correlated with the course of 
cutaneous disease in susceptible and resistant mice. TNF did not exert a direct 
leishmanicidal effect in uitro. Furthermore, our study indicated that macrophages 
are the source of L. major-induced TNF activity and that its elicitation is 
dependent on the presence of T cells. These findings suggest that TNF acts in 
concert with other cytokines produced during L. major infection and that its role 
depends on the composition of T cell subsets and cytokines present. 
Keywords: tumour necrosis factor-a, cytokines, Leishmania major, immunoregu- 
lation, mice 
Introduction 
Tumour necrosis factor-a (TNF, cachectin) is a multifunctional cytokine that is produced 
predominantly by macrophages and exerts diverse effects on a wide variety of cells 
including tumour cells, lymphocytes, fibroblasts and endothelial cells (Beutler & Cerami 
1989). TNF has been shown to mediate inflammation caused by endotoxin of Gram- 
negative bacteria (Carswell e t  al. 1975) and to influence macrophage interaction with 
protozoan parasites (DeTitto, Catterall & Remington 1986, Kongshavn & Ghadirian 
1988, Wirth & Kierszenbaum 1988) and intracellular bacteria (Bermudez & Young 1988). 
The role of TNF has been analysed in a variety of infectious diseases and conflicting 
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results have been obtained from these studies. TNF levels are frequently increased in 
patients with kala-azar (Scuderi et al. 1986) or with severe Plasmodium falciparum 
infections and recent experimental work has supported the view that T N F  may account 
for the pathological features of murine cerebral malaria (Clark ei al. 1987, Grau et al. 
1987). In the serum of patients with meningococcal septicaemia, high T N F  levels 
correlated with a negative outcome of disease (Waage, Halstensen & Espevik 1987). On 
the other hand, plasma levels of T N F  were low in lepromatous leprosy as compared to 
tuberculoid leprosy patients (Silva & Foss 1989) and a protective role of T N F  has been 
reported for murine infections with Bacillus Calmette-Gukrin (BCG; Kindler er al. 1989), 
Listeria monocytogenes (Have11 1987, Nakane, Minagawa & Kato 1988) and Escherichia 
coli (Cross er al. 1989). 
Leishmania major, the cause of cutaneous leishmaniasis. is a digenetic protozoan 
parasite alternating between the promastigote form in the sandfly vector and the 
obligatory intracellular amastigote form that resides in phagolysosomes of the mam- 
malian host’s macrophages. The infected macrophagc is supposed to be the target of the 
immune response mediated by L. major-specific Tcells (Louis & Milon 1987). The course 
of disease in mice depends on the strain of animals used. Mice of genetically resistant 
inbred strains (e.g., C57BL/6) can control the infection with lesions healing completely, 
whereas genetically susceptible mice (e.g., BALB/c) develop progressive disease with 
lethal outcome. T cell-deficient nude mice of all genotypes are highly susceptible 
(Handman, Ceredig & Mitchell 1979). Since macrophages are an important effector 
component in host resistance to L. major, we considered it of interest to investigate the 
production of TNF in L. major-infected healer and non-healer mice and to correlate the 
level of TNF release with the state of disease. In the studies to be presented, we show that 
infection with L. major primed mice for release of TNF in uico, in response to endotoxin, 
as well as in uitro, in response to either endotoxin or L. major promastigotes. In addition, i t  
was found that the L. major-induced TNF activity of macrophages was dependent on the 
presence of T cells. 
Materials and methods 
MICE 
Female mice of the inbred strains BALB/c and C57BL/6 were used at  an age of 5-12 
weeks. Female athymic BALB/c nu/nu (nude) mice were 5-7 weeks of age at the 
commencement of experiments. All mice were purchased from Charles River Breeding 
Laboratories (Sulzfeld, FRG) and, during experimentation, were maintained under 
conventional conditions in an isolation facility. 
C U L T U R E  MEDIUM 
RPMI 1640 medium (GIBCO, Karlsruhe, FRG) was supplemented with L-glutamine 
(2 mM), Hepes buffer (10 mM), NaHCO, (7.5%), 5 x 10-5 M 2-mercaptoethanol, penicillin 
(100 pg/ml), gentamycin (160 pg/ml) and 10% fetal calf serum (Seromed, Berlin, FRG) 
selected for low endotoxin content (4.2 ng/ml as determined by the supplier). 
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PARASITES, INFECTION OF MICE A N D  ASSESSMENT O F  LESlOSS 
The origin and propagation of the L. major isolate has been described in detail elsewhere 
(Solbach, Forberg & Rollinghoff 1986a). The cloned virulent line used for this study was 
confirmed to be L. major by isoenzyme analysis (Dr D.Evans, London School of Hygiene 
and Tropical Medicine, London, UK) and was maintained by passage in BALB/c mice. 
Promastigotes were grown in uitro in blood agar cultures (Solbach et al. 1986b). 
Stationary-phase promastigotes were washed in phosphate-buffered saline (PBS) and 
2 x lo6 organisms were injected in a volume of 50 pl intradermally (i.d.) on the dorsum of 
the mouse close to the base of the tail. Lesion scores were determined at regular intervals 
according to the following system: 0 =no lesion or healed scar; 1 =small swelling (up to 5 
mm in average diameter); 2 =large swelling (more than 5 mm in average diameter) or 
open lesion of less than 5 mm in average diameter; 3 =open lesion of 5- 10 mm in average 
diameter; 4=open lesion greater than 10 mm in diameter and/or obvious metastases. 
INDUCTION O F  T N F  PRODUCTION IN VIVO 
At various times after infection with L. major or 10 days after infection with 2 x lo7 BCG 
(Connaught Laboratories, Willowdale, Canada), groups of 3 mice were intravenously 
(i.v.) injected with 10 pg LPS from E. coli serotype 055:B5 (Difco. Detroit, USA) in a 
volume of 0.1 ml. After 2 h, mice were bled and serum was collected for subsequent 
determination of T N F  activity. 
INDUCTION OF T N F  PRODUCTION IN VITRO 
T cells were separated from whole spleen and lymph node cell suspensions by passage 
through a nylon wool followed by a Sephadex GI0 (Pharmacia, Uppsala, Sweden) 
column. For preparation of macrophages, spleens were cut into small pieces and were 
digested in a solution containing 1.5 mg/ml pronase (Boehringer. Mannheim, FRG) and 
100 pg/ml DNase (Boehringer) under continuous rotation (50 rpm, 37°C. 30 min) in 
90-mm tissue culture dishes (Greiner, Niirtingen, FRG), as described elsewhere 
(Hockertz et al. 1986). After erythrocyte lysis and washing (in the presence of DNase), 4- 
5 x IO’celIs in 15 ml culture medium were incubated in a tissue culture dish for 24 h (37”, 
5% COz). Subsequently, the non-adherent cells were carefully removed from the 
monolayer of adherent cells by repeated washing with warm (37-C) culture medium. The 
dishes were put on ice for 1 h to allow the collection of the adherent population which was 
virtually free of lymphocytes as judged by subsequent staining with fluoresceinated anti- 
Thy-I and anti-immunoglobulin antibodies. More than 95% of the adherent cells were 
shown to be macrophages by May-Griinwald-Giemsa and non-specific esterase staining. 
For induction of TNF production, unselected spleen cells or purified T cells or 
macrophages were obtained from untreated or L. major-infected mice. 5 x lo6 spleen cells 
or 2 x lo6 T cells were placed into 2-ml cultures (Nunc, 143982; Wiesbaden, FRG) and 
I x 10’ macrophages were cultured in flat-bottom microtitre plates (Nunc, 167008) in a 
volume of 0.2 ml. The cells were stimulated with the mitogens LPS (10 pg/ml) or 
concanavalin A (Con A; 2.5 pg/ml; Serva, Heidelberg, FRG) or with live L. major 
promastigotes ( 1  x 106/ml) collected during the stationary phase of growth. After 6 h 
(mitogen stimulation) or 24 h (L .  major stimulation) of culture, supernatants were 
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ASSESSMENT OF T N F  ACTIVITY 
For the detection of biologically active TNF and lymphotoxin (LT, TNF-#I) in sera and 
culture supernatants, cells of the fibrosarcoma line WEHI 164, which are highly sensitive 
to the cytolytic effects of both cytokines, were used as target cells (Okuno er ul. 1986). In 
the presence or absence of a polyvalent antiserum specific for murine T N F  (100 
neutralizing units (U); Genzyme, Boston, USA), samples were tested for cytotoxic 
activity by incubating serial dilutions (50% initial concentration) with 2 x lo4 WEHI 164 
cells and actinomycin D (0.5 pg/ml; Sigma, Deisenhofen, FRG) in a volume of 0.2 ml in 
flat-bottom microtitre plates. For quantification of viable cells, the colorimetric MTT (3- 
(4.5dimethyl thiazol-2-yl)-2,5-diphenyl-tetrazolium bromide) assay was used (Tada er al. 
1986). After 24 h incubation, MTT (Sigma) was added (10 pl of MTT solution Of 5 mg/ml 
in PBS), and 5 h later, cultures were supplemented with 100 pl of 10% sodium dodecyl 
sulphate (SDS) in 0.01 N HCI and incubated overnight at 37'C. The absorbance was 
measured with a microplate reader (MR 700; Dynatech, Denkendorf, FRG), using a test 
wavelength of 550 nm and a reference wavelength of 670 nm. In this assay, the optical 
density (OD) values are inversely related to the degree of cytotoxic activity mediated by 
TNF.  A standard titration of recombinant murine TNF (rTNF, kindly provided by Dr 
G.R.Adolf, Emst-Boehringer-Institut, Vienna, Austria)at dilutions ranging from 2 U/ml 
to 0.016 U/ml was set up with each assay ( 1  U-38.5 pg rTNF as determined by the 
supplier in a bioassay with murine tumour cells). The data were subjected to probit 
analysis, compared to the standard curve, and the activity ofeach sample wasexpressed in 
units of TNF. The detection threshold of the colorimetric assay for TNF activity was 0.5 
U/ml. 
Results 
EFFECT OF T N F  ON GROWTH OF L. MAJOR IN VITRO 
Previous studies have shown that rTNF is able to inhibit the growth of trypanosomes in 
virro even at  very low concentrations (Kongshavn & Ghadirian 1988). To determine 
whether TNF also affects the in v i m  proliferation of L. major, rTNF at concentrations 
ranging from 10' to 5 x lo3 U/ml was added to promastigote cultures and the parasite 
content was determined 3 days later using the colorimetric MTT assay (Table I). It was 
found that the growth of L. major promastigotes was not altered by any of the TNF 
concentrations tested. Thus. TNF does not seem to exert a direct leishmanicidal effect. 
T N F  ACTIVITY IN SERA OF L. MAJOR-INFECTED MICE 
We determined the TNF level in serum of either genetically susceptible or genetically 
resistant mice infected with L. major in order to correlate the capacity to produce TNF 
with the course of cutaneous disease. At various intervals after i.d. infection with L. major, 
susceptible BALB/c and resistant C57BL/6 mice were challenged i.v. with LPS. Sera were 
collected 2 h later and pooled for determination of the TNF activity of individual 
experimental groups. The results in Figure 1 show that TNF activity could be detected in 
sera of both BALB/c and C57BL/6 mice infected with L. major. Serum TNF titres of 
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Table 1. Effect ofrTNF on the growth of 
L. major promastigotes in uitro* 
OD values 
rTNF (U/ml) mean f s.d. 
5000 
1250 
310 
80 
10 
0 
0.376 f 0.033 
0.368 f 0.03 1 
0.377 f 0.024 
0.370 f 0.01 3 
0.322 f 0.029 
0.353 f 0.01 3 
* Blood agar cultures containing L.  
major promastigotes ( 1  x loJ in 0.1 ml) 
and various concentrations of  rTNF 
were incubated at 26°C for 3 days. 
Subsequently, 0.1 ml of  parasite suspen- 
sion were collected from each culture 
and were transferred to fresh microcul- 
ture wells in order to quantify the living 
promastigotes by using the colorimetric 
MTT assay. Each value represents the 
mean f s.d. of  triplicate cultures. 
OD: optical density. 
BALB/c mice increased with progressing infection, whereas those of C57BL/6 mice 
peaked at a much lower level. In a control experiment with BCG-infected C57BL/6 mice 
challenged with LPS, high titres of TNF could be demonstrated showing that mice of this 
strain are well capable of releasing this factor. The results obtained with BCG-treated 
mice are in agreement with other reports showing that C57BY6 mice are high-responders 
and BALB/c mice are low-responders with respect to endotoxin-induced T N F  produc- 
tion after BCG priming (Haranaka, Satomi & Sakurai 1984). LPS-induced production of 
TNF was dependent on prior infection with L. major or BCG since no significant amounts 
of TNF could be detected in sera of uninfected mice (data not shown). In the absence of 
LPS stimulation, L. major-infected mice of either strain failed to elicit TNF activity (data 
not shown). Athymic nude mice infected with L. major elicited only low titres of LPS- 
induced serum TNF (80-300 U/ml) even though they develop progressive disease. This 
T N F  activity was in the same order of magnitude as that detected in sera of uninfected 
nude mice challenged with LPS (data not shown). 
In order to discriminate between the cytotoxic factors T N F  and LT, both of which 
have the capacity to lyse WEHI 164 cells in uitro, we added an antiserum specific for TNF 
to the in uitro assay used for determination of TNF titres. The TNF activity detected in the 
serum samples was completely neutralized in the presence of this antiserum (data not 
shown). These results show that TNF alone but not LT accounts for the LPS-induced 
cytotoxic factor in the serum of L. major-infected mice. 
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Figure 1. Course of lesion development (a) and LPS-induced TNF activity (b) in sera of BALB/c (0. 
open bars) and C57BL/6 (W, closed bars) mice infected with 2 x lo6 L. major promastigotes. At 
various intervals after i.d. infection, cutaneous lesion scores were determined (a) and mice were 
injected with 10 pg LPS i.v. (b). In a control experiment, mice were infected with 2 x lo7 BCG and 
were challenged with LPS 10 days later. Blood was collected 1 h after administration of LPS, and 
serum TNF titres were determined according to the cytotoxicity against WEHI 164 cells in the 
colorimetric MTT assay. Three mice were used for each time point. Arithmetic means of the 
cutaneous lesion scores (as defined in Materials and methods) are given with the respective standard 
errors (a). The standard errors in the TNF assays were consistently below 5% (b). * Not tested. 
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T N F  PRODUCTION OF CELLS FROM L.  MAJOR-INFECTED MICE IN RESPONSE TO 
MITOGEN STIMULATION IN VITRO 
At various times of infection with L. major, unseparated spleen cells or purified spleen 
macrophages from BALB/c and C57BL/6 mice were stimulated with LPS in vitro. After 6 
h, which was found to be the time of maximal LPS-induced T N F  release, culture 
supernatants were collected and assayed for TNF activity. As it has been observed for 
other infectious diseases (Have11 1987, Tarleton 1988), the TNF levels detected after in 
vitro stimulation were generally much lower than those found in the serum of infected 
mice challenged with LPS. However, they were significantly above background and 
reproducible in numerous experiments. In cultures of whole spleen cells, the TNF 
response was more pronounced for BALB/c than for C57BL/6 mice infected with 
L. major and increased with severeness of disease (Figure 2a). These results confirm the 
data obtained with serum samples from infected mice. On the other hand, purified 
macrophages from infected BALB/c and C57BL/6 mice did not differ consistently in their 
ability to release LPS-induced T N F  (Figure 2b). This suggests that the enhanced capacity 
of TNF production of L. major-infected BALB/c mice is caused by the increased 
proportion of macrophages in these animals (Modabber 1987; C.Bogdan and W.Solbach, 
unpublished observations). As it was the case for the serum samples, all the TNF activity 
in culture supernatants was totally abrogated by anti-TNF antiserum (data not shown). 
T cells purified from the spleens and lymph nodes of L. major-infected mice failed to 
release TNF upon in uitro stimulation with the mitogen Con A (Figure 2c). Their 
functional integrity was confirmed by the ability to produce interleukin 2 (IL-2; data not 
shown), as it was expected from mitogen-stimulated T cells obtained from primed mice. 
These results provided evidence for macrophages being the predominant source of TNF 
in mice with cutaneous leishmaniasis. 
T N F  PRODUCTION OF CELLS FROM L.  MAJOR-INFECTED MICE IN RESPONSE TO 
IN VITRO RESTIMULATION WITH L. MAJOR 
In view of the finding that infection with L. major can prime mice for LPS-induced TNF 
production both in viuo and in uitro, studies were carried out to determine the capacity of 
these animals to release TNF in response to in vitro restimulation with L. major. In 
analogy to the in vitro assay system described above, spleen cells or macrophages were 
prepared at various intervals after infection and were cultured with live L. major 
promastigotes in vitro. Culture supernatants collected after 24 h of incubation were found 
to contain a maximum of L. major-induced TNF activity. The results presented in Figure 
3 show that spleen cells from both infected BALB/c and C57BL/6 mice were able to 
release TNF in response to L.  major alone (in the absence of mitogen). We could not 
detect consistent differences in the T N F  levels produced by those mice. However, no TNF 
activity could be detected in cultures of purified macrophages (data not shown) even 
though the same preparations of macrophages were very well able to produce TNF upon 
LPS challenge (see above, Figure 2b). Therefore, we conclude that the elicitation of TNF 
activity in response to L. major infection is dependent on the presence of T cells. 
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Figure 2. TNF activity of cells from infected BALB/c (open bars) and C57BL/6 (closed bars) mice in 
response to mitogen stimulation in vitro. At various times after i.d. infection with 2 x lo6 L.  major 
promastigotes, mice were killed and 5 x lo6 unselected spleen cells in 2-ml cultures (a) or 1 x lo5 
purified macrophages in cultures ofO.2 ml (b) were stimulated with 10 pg/ml of LPS. Cultures (2 ml) 
of 2 x lo6 purified T cells from spleens and lymph nodes (c) were stimulated with 2.5 pgjml of Con A. 
After 6 h incubation, supernatants were collected and assayed for TNF activity in the MTT assay. 
The s.d. were consistently below 5%. * Not tested. 
TNF production during leishmaniasis 49 1 
I 2  3 4 S 6 7 8 9 10 
Time a f te r  infection (weeks1 
Figure 3. TNF activity of cells from infected BALB/c (open bars) and C57BL/6 (closed bars) mice 
after in uitro restimulation with L. major. At various intervals after i.d. infection of mice with 2 x lo6 
L. major promastigotes, 5 x lo6 unselected spleen cells in 2-ml cultures were stimulated with L. 
major promastigotes ( I  x IOb/ml). After 24 h incubation. supernatants were collected and assayed 
for TNF activity in the MTT assay. The s.d. were consistently below 5%.  * Not tested. 
Discussion 
Significant serum levels of T N F  are generally induced by an initial priming step and a 
subsequent secondary stimulus, usually bacterial LPS (Carswell et al. 1975, Beutler & 
Cerami 1989). Upon challenge with LPS, serum T N F  activity could be detected in both 
genetically susceptible BALB/c and genetically resistant C57BL/6 mice infected with L. 
major. However, the TNF titres were markedly higher in BALB/c than in C57BL/6 mice 
and increased with progression of disease in susceptible mice. Thus, the LPS-induced 
T N F  activity in the serum appeared to correlate with severeness of cutaneous 
leishmaniasis. On the other hand, the TNF activity in sera from athymic BALB/c nude 
mice challenged with LPS was not significantly increased after infection with L. major, 
even though these animals are susceptible to the disease. However, previous reports have 
already pointed out that nude mice differ from euthymic mice in their ability to  produce 
TNF (Haranaka et al. 1984). Even in chronically infected BALB/c mice, no serum T N F  
activity could be detected in the absence of an LPS stimulus. Similar findings have been 
reported for other bacterial and protozoal infections (Nakane et al. 1988, Tarleton 1988). 
However, our observation that spleen cells from infected mice are able to release TNF 
after in vitro restimulation with live L. major promastigotes strongly suggests that 
infection with L. major results in the production of TNF in cico in the absence of an LPS 
challenge. The L. major-induced T N F  release may be restricted to the sites of infection 
and may therefore not be detectable in the serum, as it has been observed in mice infected 
with BCG (Kindler et al. 1989). Alternatively, the levels of T N F  secreted under natural 
conditions may be lower than those induced by LPS and the rapid clearance of TNF from 
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the circulation (Beutler, Milsark & Cerami 1985) may thus prevent its detection in the 
serum of L. major-infected mice. 
While this paper was in review, a report was published that suggested a beneficial 
effect o fTNF on leishmaniasis (Titus, Sherry & Cerami 1989). The TNF was proposed to 
originate from T cells in infected mice and to inhibit parasite replication in macrophages. 
In the present study, however, we showed that TNF activity was detected exclusively in 
mitogen-stimulated cultures containing purified macrophages but not in those of purified 
T cells. Therefore, the TNF activity elicited by L. major-infected mice is likely to be 
produced by macrophages. Furthermore, we demonstrated that TNF alone, in the 
absence of interferon-y (IFN-)I) or LPS, failed to activate macrophages for killing of L. 
major amastigotes (Bogdan et al. 1990). 
After in vitro stimulation with live L. major promastigotes, TNF activity could only be 
detected in cultures of unseparated spleen cells but not in those of purified macrophages 
from infected mice. These results favour the notion that the presence o fT  cells is required 
for the elaboration of TNF activity by macrophages in response to L. major infection, an 
interpretation which is supported by our finding that athymic nude mice infected with L. 
major elicited only low titres of serum TNF. Some T cell products such as IL-3, 
granulocyte-macrophage colony-stimulating factor (GM-CSF) or IFN-y are known to 
stimulate the differentiation of macrophages and the release of TNF (Collart et al. 1986, 
Heidenreich er al. 1989). The T cell dependence of the expression of TNF activity during 
cutaneous leishmaniasis is reminiscent of the situation in mice with cerebral malaria 
where T cells of the L3T4 subpopulation have been implicated in the induction of high 
levels of serum TNF (Grau et al. 1987). 
The present study has shown that the levels of LPS-induced TNF production are 
different in susceptible and resistant mice infected with L. major, due to differences in the 
number of macrophages present, whereas the L. major-stimulated TNF activity is equally 
expressed in both susceptible and resistant mice. So, what role may T N F  play in the 
pathogenesis ofcutaneous leishmaniasis? Since the immune response to L. major is known 
to be mediated by different subsets of T cells and various T-cell-derived lymphokines have 
been shown to influence the outcome of murine disease (Greil et al. 1988, Lelchuk, 
Graveley & Liew 1988, Heinzel et al. 1989), the effect o fTNF is likely to be connected with 
the availability of other cytokines. Interactions of TNF with various cytokines have been 
documented in a number of experimental systems. TNF augments the production of GM- 
CSF by a variety of cell types (Munker et al. 1986) and it stimulates the release of IL-1 
from macrophages (Dinarello et al. 1986). TNF and IFN-y act synergistically to induce 
macrophage killing of tumour cells and schistosomula of Schisrosoriia mansoni (Esparza 
el al. 1987). In view of these interactions, it seems conceivable that TNF exerts different 
effects in susceptible and resistant mice infected with L. major. This notion is supported by 
in vitro studies with macrophages stimulated with various combinations of recombinant 
cytokines. In combination with IFN-y, a lymphokine produced in L. major-infected mice 
of resistant strains, TNF induced the elimination of parasites in infected macrophages, 
whereas it promoted parasite burden in the presence of IL-4 which is mainly expressed in 
susceptible mice (Bogdan et al. 1990). Thus, TNF may have both beneficial and 
deleterious effects on the infection with L. major, as it has been observed for viral 
meningitis (Doherty, Allan & Clark 1989) and malaria (Clark er al. 1987. Grau et al. 1987, 
Taverne et al. 1987). More studies on the synergistic actions of cytokines are required in 
order to elucidate the cascade of events resulting in either resistance or susceptibility to 
cutaneous leishmaniasis. 
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